Oncor
Maryland
Clinical testing and research utilizing genetic molecular technology. Associated instrumentation for image analysis and pharmaceutical inspection
Merger and acquisition strategic planning and development
Early genetic diagnostic firm with first to market FISH test for breast cancer. Expanded markets included pharmaceutical controls and clinical lab services.
Managed and advised divestiture on technical products and core-technology no longer fitting company strategic plans.